EMBECTA CORP. - COMMON STOCK

Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results

09 Feb 2024 06:30:00 By Nasdaq GlobeNewswire

embecta Announces Quarterly Cash Dividend

09 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

embecta to Participate in the 11th Annual BTIG MedTech Conference

07 Feb 2024 17:00:00 By Nasdaq GlobeNewswire

embecta to Report Fiscal First Quarter 2024 Financial Results

24 Jan 2024 17:00:00 By Nasdaq GlobeNewswire

embecta Announces FDA 510(k) Submission for Insulin Patch Pump

09 Jan 2024 06:00:00 By Nasdaq GlobeNewswire

embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

14 Dec 2023 17:00:00 By Nasdaq GlobeNewswire

No embecta-made syringes impacted by FDA safety communication

01 Dec 2023 06:00:00 By Nasdaq GlobeNewswire

embecta to Participate in Investor Conferences

29 Nov 2023 17:00:00 By Nasdaq GlobeNewswire

Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance

21 Nov 2023 05:30:00 By Nasdaq GlobeNewswire

embecta Announces Quarterly Cash Dividend

21 Nov 2023 05:00:00 By Nasdaq GlobeNewswire

embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell

31 Oct 2023 06:50:00 By Nasdaq GlobeNewswire

embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results

25 Oct 2023 17:00:00 By Nasdaq GlobeNewswire

embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference

06 Sep 2023 17:00:00 By Nasdaq GlobeNewswire

Embecta Corp. Reports Third Quarter Fiscal 2023 Financial Results

08 Aug 2023 06:30:00 By Nasdaq GlobeNewswire

embecta Announces Quarterly Cash Dividend

08 Aug 2023 06:00:00 By Nasdaq GlobeNewswire

embecta to Report Fiscal Third Quarter 2023 Financial Results

11 Jul 2023 17:00:00 By Nasdaq GlobeNewswire

UPDATE -- embecta to Participate in Investor Conferences

15 May 2023 17:38:43 By Nasdaq GlobeNewswire

embecta to Participate in Investor Conferences

15 May 2023 17:00:00 By Nasdaq GlobeNewswire

Embecta Corp. Reports Second Quarter Fiscal 2023 Financial Results

12 May 2023 06:30:00 By Nasdaq GlobeNewswire

embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes

12 May 2023 06:15:00 By Nasdaq GlobeNewswire